Bionano Genomics

General Information
Business:

We are a life sciences instrumentation company in the genome analysis space. We develop and market the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Our Saphyr system comprises an instrument, chip consumables, reagents and a suite of data analysis tools.

Industry: LABORATORY ANALYTICAL INSTRUMENTS
Employees: 65
Founded: 2003
Contact Information
Address 9640 Towne Centre Drive, Suite 100, San Diego, CA 92121, US
Phone Number (858) 888-7600
Web Address http://www.bionanogenomics.com
View Prospectus: Bionano Genomics
Financial Information
Market Cap $102.8mil
Revenues $11.1 mil (last 12 months)
Net Income $-18.2 mil (last 12 months)
IPO Profile
Symbol BNGO
Exchange NASDAQ
Shares (millions): 3.4
Price range $8.00 - $10.00
Est. $ Volume $30.2 mil
Manager / Joint Managers Roth Capital Partners
CO-Managers Maxim Group
Expected To Trade: 7/30/2018
Day: Week of
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change